Anti-tumor activities of peptides corresponding to conserved complementary determining regions from different immunoglobulins

Anti-tumor activities of peptides corresponding to conserved complementary determining regions from different immunoglobulins

Author Figueiredo, Carlos R. Autor UNIFESP Google Scholar
Matsuo, Alisson L. Autor UNIFESP Google Scholar
Massaoka, Mariana H. Autor UNIFESP Google Scholar
Polonelli, Luciano Google Scholar
Travassos, Luiz R. Autor UNIFESP Google Scholar
Institution Universidade Federal de São Paulo (UNIFESP)
Univ Parma
Recepta Biopharma
Abstract Short synthetic peptides corresponding to sequences of complementarity-determining regions (CDRs) from different immunoglobulin families have been shown to induce antimicrobial, antiviral and antitumor activities regardless of the specificity of the original monoclonal antibody (mAb). Presently, we studied the in vitro and in vivo antitumor activity of synthetic peptides derived from conserved CDR sequences of different immunoglobulins against human tumor cell lines and murine B16F10-Nex2 melanoma aiming at the discovery of candidate molecules for cancer therapy. Four light-and heavy-chain CDR peptide sequences from different antibodies (C36-L1, HA9-H2, 1-H2 and Mg16-H2) showed cytotoxic activity against murine melanoma and a panel of human tumor cell lineages in vitro. Importantly, theyalso exerted anti-metastatic activity using a syngeneic melanoma model in mice. Other peptides (D07-H3, MN20v1, MS2-H3) were also protective against metastatic melanoma, without showing significant cytotoxicity against tumor cells in vitro. in this case, we suggest that these peptides may act as immune adjuvants in vivo. As observed, peptides induced nitric oxide production in bone-marrow macrophages showing that innate immune cells can also be modulated by these CDR peptides. the present screening supports the search in immunoglobulins of rather frequent CDR sequences that are endowed with specific antitumor properties and may be candidates to be developed as anti-cancer drugs. (C) 2014 Elsevier Inc. All rights reserved.
Keywords Peptide
CDR
Cytotoxicity
Antitumor activity
Melanoma
Language English
Sponsor Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Grant number FAPESP: 2010/51423-0
Date 2014-09-01
Published in Peptides. New York: Elsevier B.V., v. 59, p. 14-19, 2014.
ISSN 0196-9781 (Sherpa/Romeo, impact factor)
Publisher Elsevier B.V.
Extent 14-19
Origin http://dx.doi.org/10.1016/j.peptides.2014.06.007
Access rights Closed access
Type Article
Web of Science ID WOS:000341427300003
URI http://repositorio.unifesp.br/handle/11600/38174

Show full item record




File

File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Search


Browse

Statistics

My Account